🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Don’t miss an opportunity to pitch your potential precision oncology innovation to J&J oncology leaders! Apply to the Pitching Asia Pacific Oncology Innovation QuickFire Challenge by June 6: jji.jnj/aponc25

We’re partnering with top VCs for Reverse Pitch: The VC Edition June 5 | 4–6 PM @ JLABS NYC. Hear from JJDC, Curie Bio, and Two Bear Capital on what investors really want in a live reverse pitch + panel format. Register: jji.jnj/3SvbjAW

Thank you to all who attended the second Life Sciences Innovation Evening with J&J in London! We had a great turn-out yesterday, connecting with some brilliant minds in the ecosystem. Learn more about the upcoming June session & book your place now. jji.jnj/4i96cRm

From lab bench to business model, hear about different routes for turning drug discoveries into patient-ready solutions at our ‘Paths to the Patients’ event this June jji.jnj/3EKW6Zf

Thank you to everyone who joined us at USC for the Johnson & Johnson Innovation LA Roadshow and a special thanks to speakers Juan Cueva and Georgina Jones Suzuki for their sharing valuable perspectives with attendees. This was truly an impactful day!

Innovators in respiratory science—this is your moment. Submit your solutions for non-T2 Asthma and/or COPD for a chance to pitch J&J leaders. Deadline: July 11.

Are you working to turn a scientific breakthrough into patient impact? Let's discuss the critical decisions involved in the trajectory of early drug development. Save your seat here: jji.jnj/4jRwkRQ

We're excited to return to Boston in a few short weeks for BIO 2025. Leaders from across J&J will be participating in sessions all week, and our team will be in attendance looking to connect with attendees. Will you be there? jji.jnj/4msP9Ny

Don’t miss the chance to present your science to J&J leaders! Apply to the Pitching Asia Pacific #Oncology Innovation QuickFireChallenge by June 6: jji.jnj/aponc25

Our leaders are gearing up for BIO 2025, where they'll be speaking on panels centered around innovation and regulation, trends in dealmaking, and accelerating clinical breakthroughs. Learn more here: jji.jnj/4msP9Ny

Join Stacy Feld, Global Head, External Scientific Innovation, at BioCentury Grand Rounds 2025 in a panel discussion on key tips to engage with pharma partners such as Johnson & Johnson. Hope to see you in Chicago! bit.ly/4dxdPQS

Just one more day to submit your potential solutions aimed at advancing anticancer therapeutics for patients. Apply by June 6: jji.jnj/aponc25

A great conversation was had at BioCentury Grand Rounds 2025 with Stacy Feld and industry colleagues as they shared practical advice for innovators and early-stage biotech companies on how to navigate pharma partnerships.

We’re heading back to BIO next week, and looking forward to connecting with attendees onsite. To learn more about what we’ll be doing onsite, and how we’ll be using this time to connect, engage, and learn from our industry peers, click here: jji.jnj/3FPBwr7

We’re proud of the work JLABS has done so far, proving again that a good idea can come from anywhere. See where we’ve been, and where we’re going next in our latest blog.

Next week we are heading to Boston for BIO 2025. We're looking forward to meeting attendees and discussing the future of innovation. Stop by our partnering suite to meet with our team and be sure to attend a session or two featuring our leadership! jji.jnj/4msP9Ny

We're here at BIO looking forward to learning, growing, and meeting like-minded teams looking to push the future of biotech forward. Stop by our partnering suite to see how we can collaborate.

Don’t miss a chance to share your neuroscience innovations! Apply to the Korea Innovation QuickFire Challenge: Targeting Neuroscience by August 1: jji.jnj/KIQFC25

Day 2 of BIO is off to a great start. Penny Heaton and Nauman Shah participated in a fireside chat and gave attendees insight into our innovation model, and how its used to accelerate a new standard of patient care.

Thank you to everyone who participated in the company presentations this week at BIO. It was exciting to see so many teams coming together to innovate and change the future of healthcare.